Precision Biosciences initiates patient enrollment in PBGENE-DMD clinical study
Immunome submits FDA application for varegacestat following strong Phase 3 results
HUTCHMED secures priority review for sovleplenib NDA in China
Chiesi Group to acquire KalVista Pharmaceuticals for USD1.9bn in rare disease expansion strategy
Circio partners with USC to advance non-viral RNA delivery technologies
Cirius Therapeutics introduces gestational diabetes initiative
Vanda Pharmaceuticals reports publication of imsidolimab phase III findings in NEJM Evidence
GSK hepatitis B therapy bepirovirsen gains FDA priority review and breakthrough designation